Recombinant Human Relaxin in the Treatment of Scleroderma

Author:

Seibold James R.12,Korn Joseph H.12,Simms Robert12,Clements Phillip J.12,Moreland Larry W.12,Mayes Maureen D.12,Furst Daniel E.12,Rothfield Naomi12,Steen Virginia12,Weisman Michael12,Collier David12,Wigley Fredrick M.12,Merkel Peter A.12,Csuka Mary Ellen12,Hsu Vivien12,Rocco Susan12,Erikson Mark12,Hannigan John12,Harkonen W. Scott12,Sanders Martin E.12

Affiliation:

1. From University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick, New Jersey; Boston University Medical Center and Massachusetts General Hospital, Boston, Massachusetts; University of California, Los Angeles, School of Medicine, Los Angeles, California; University of Alabama at Birmingham, Birmingham, Alabama; Wayne State University, Detroit, Michigan; Virginia Mason Research Center, Seattle, Washington;

2. University of Connecticut Health Center, Farmington, Connecticut; Georgetown University Medical Center, Washington, D.C.; University of California, San Diego, San Diego, California; University of Colorado Health Sciences Center, Denver, Colorado; Johns Hopkins Bayview Medical Center, Baltimore, Maryland; Medical College of Wisconsin, Milwaukee, Wisconsin; and Connetics Corp., Palo Alto, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 224 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Autoimmune Disease;Obstetric Anesthesia and Uncommon Disorders;2024-02-01

2. Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis;International Journal of Molecular Sciences;2023-05-14

3. Role of rituximab in the treatment of systemic sclerosis: A literature review;Modern Rheumatology;2023-04-13

4. Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism;Frontiers in Cell and Developmental Biology;2023-04-11

5. Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosis;Science Translational Medicine;2022-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3